Home / Resources / Pharma R&D Annual Review 2024 Supplement: New Active Substances Launched During 2023

Pharma R&D Annual Review 2024 Supplement: New Active Substances Launched During 2023

Report
Clinical
Preview Report Cover for Pharma R&D Annual Review 2024 Supplement: New Active Substances Launched During 2023

In 2023, the pharmaceutical industry saw 91 NASs — 17 more than 2022, a significant boost — across 90 products (one product was a fixed-dose combination containing two NASs) making their market debuts. It was the second-best year ever in terms of the number of NAS launches.

In the evolving landscape of cancer treatment, targeted therapies continue to be a transformative technology driving innovation.
Steve Worland, CEO, eFFECTOR Therapeutics
Related products
Healthcare professional monitoring and analyzing R and D trends.
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
Discover the ultimate clinical trial benchmarking tool
Expert analyst presenting data insights on a projected screen.
Biomedtracker
Real-time tracking and analysis of the drug development pipeline

Related resources

Citeline Clinical Infographic: A Promising Rebound Selected Insights from the Annual Clinical Trials Roundup: 2024 Edition
OCT 10, 2024
Infographic
Clinical

The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

The rebound in clinical trial starts in 2023 signals a return to form after last year’s decline.

A variety of pills and tablets arranged neatly on a wooden table surface
OCT 09, 2024
Report
Commercial

Key Potential Drug Launches in 2025

Biomedtracker’s Key Potential Drug Launches in 2025 report provides a longer-term look at some key late-stage drugs projected to hit the market in 2025.

AI
OCT 11, 2024
White paper
Clinical

AI in Pharma: Benefits, Risks, and the Road Ahead

AI is being used to streamline and accelerate each step of the drug development process from research through approval and marketing.

View all
Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.